Brussels, Belgium, 18 July 2018 – A new Antimicrobial Resistance (AMR) Accelerator Programme is part of new Calls for proposals launched today by the Innovative Medicines Initiative (IMI). Of the other topics launched in the Calls, many address brain disorders (e.g. Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, major depression) and immune-mediated diseases (e.g. rheumatoid arthritis …

by Heather Smith

£2.5BN British Patient Capital Programme Launched To Enable Long-Term Investment In Innovative Companies Across The UK British Patient Capital fulfils the Chancellor’s 2017 Autumn Budget commitment and one of the outcomes of the Patient Capital Review British Patient Capital will support UK businesses with high growth potential to access the long-term financing that will enable …

by Heather Smith
1 30 31 32
EnglishFrenchItalianPortugueseSpanish